Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-24

Clinical Trial Update: Efficacy of a New Thickened Extensively Hydrolyzed Formula [NA]

View source ↗

Summary

A completed clinical trial evaluating the efficacy of a thickened extensively hydrolyzed formula for cow's milk protein allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thickened Extensively Hydrolyzed Formula

Snippet

Sponsor: United Pharmaceuticals | Conditions: Protein Allergy, Cow's Milk Protein Hypersensitivity | NA | Status: COMPLETED